What is zanubrutinib?
Answer:
Zanubrutinib is a targeted cancer therapy known as a Bruton's tyrosine kinase (BTK) inhibitor. It works by blocking a protein leukemia cells depend on to grow and survive. Unlike traditional chemotherapy, targeted therapies focus on specific biological pathways involved in cancer development.